How Tumors Evade Immunity and What Can Be Done
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 3-34
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 35-48
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 49-65
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 67-86
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 87-99
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 101-117
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 119-144
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 145-156
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 157-172
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 173-194
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 195-213
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Basic Mechanisms of Immune Evasion > 215-234
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Clinical Relevance of Immune Evasion > 237-255
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Clinical Relevance of Immune Evasion > 257-277
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Clinical Relevance of Immune Evasion > 279-293
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Clinical Relevance of Immune Evasion > 295-314
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Clinical Relevance of Immune Evasion > 315-334
Current Clinical Oncology > Cancer Immunotherapy at the Crossroads > Clinical Relevance of Immune Evasion > 335-350